MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 15:01
529.25
-1.05 (-0.2%)
VOLUME 108,779
LIVE
NSE
May 28, 15:01
529.35
-0.8 (-0.15%)
VOLUME 961,413
Business News on Ranbaxy Laboratories
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Teva will get part of profit from Lipitor sale by Ranbaxy 

9.20 am | 15 Dec 2011 |  Source: CNBC-TV18

Industry sources tell PharmAsia News that Ranbaxy forged the Teva Lipitor deal as a back-up plan to try and ensure an on-time launch....

Ranbaxy's ANDA transfer saw Teva launch Lipitor: PharmAsia 

9.05 pm | 14 Dec 2011 |  Source: CNBC-TV18

The deal between pharma majors Ranbaxy and Teva, for the sale of generic version of the blockbuster cholesterol drug – Lipitor left many in the indust...

Ranbaxy launches blood pressure pills in the US market 

9.50 am | 07 Dec 2011 |  Source: Moneycontrol.com

Ranbaxy Laboratories has launched an authorised generic version of Caduet in the US market, as part of an agreement with Pfizer Inc. The product is in...

Ranbaxy jumps after final nod from USFDA to launch Lipitor 

10.34 am | 01 Dec 2011 |  Source: Moneycontrol.com

Ranbaxy’s shares jumped over 10% in morning trade on Thursday after it said it has launched its generic version of Lipitor in the US market having rec...

Ranbaxy to have 30% mkt share for Lipitor: PharmAsiaNews 

8.56 am | 01 Dec 2011 |  Source: CNBC-TV18

Vikas Dandekar of PharmAsiaNews.com tells CNBC-TV18 that the US FDA approval for Lipitor is definitely going to be a big positive for Ranbaxy....

Lipitor is biggest catalyst to Ranbaxy's growth: Expert 

11.55 am | 30 Nov 2011 |  Source: CNBC-TV18

Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that Ranbaxy is most likely set to go ahead with the launch of the generic ...

Franklin Templeton PE invests Rs 45 cr in Symbiotec 

9.29 pm | 21 Sep 2011 |  Source: PTI

Franklin Templeton Private Equity Strategy (FTPES) today said it has invested Rs 45 crore in Symbiotec Pharmalab....

Lipitor generic launch on schedule says Ranbaxy 

5.45 pm | 08 Sep 2011 |  Source: CNBC-TV18

Pharma major Ranbaxy Laboratories is on track to launch the generic version of the blockbuster cholesterol drug Lipitor....

Ranbaxy sells first generic of AZ's Nexium in UK 

3.47 pm | 05 Sep 2011 |  Source: Reuters

Ranbaxy Laboratories Ltd has launched the first generic version of AstraZeneca Plc's heartburn and ulcer drug Nexium in Britain, adding to pressure on...

India's biotech sector crosses $4 bn: E&Y report 

9.10 pm | 30 Aug 2011 |  Source: PTI

Domestic biotech industry crossed the USD 4 billion-mark last fiscal, growing from around USD 3 billion in the previous fiscal, according to an Ernst ...

Cipla, Lupin deny in stake sale talks with Takeda Pharma 

4.33 pm | 24 Aug 2011 |  Source: Moneycontrol.com

Pharmaceutical companies Cipla and Lupin have both strongly denied that they are in talks with Takeda Pharmaceutical Co to sell stake or part of their...

Takeda eyes pharma business of Cipla, Lupin 

2.11 pm | 24 Aug 2011 |  Source: Reuters

Takeda Pharmaceutical Co, Japan's largest drugmaker, is in talks with Indian generic drugmakers Cipla and Lupin about buying one of the companies' pha...

Ranbaxy launches 'Volini Duo' OTC painkiller across country 

2.32 pm | 12 Aug 2011 |  Source: PTI

Drug firm Ranbaxy Laboratories today said its over-the-counter (OTC) division has launched a two-in-one painkiller, 'Volini Duo', across the country....

Ranbaxy's Sobti's Friday Gurgaon to hit stands by month-end 

7.19 pm | 10 Aug 2011 |  Source: PTI

Ranbaxy Laboratories' former CEO Atul Sobti's dream media venture 'Friday Gurgaon', a weekly newspaper, will hit the news stands by month-end....

Novartis tells SC it has right to patent blood cancer drug 

8.21 pm | 09 Aug 2011 |  Source: PTI

Swiss pharma giant Novartis AG today told the Supreme Court it had the right to patent its blood cancer drug as it was a completely new medicine and n...

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.